Preparation and characterization of etoricoxib-β-cyclodextrin complexes prepared by the kneading method

P. Leclercq and M. G. Malaise, Etoricoxib (Arcoxia), Rev. Med. Liege59 (2004) 345--349.Search in Google Scholar

D. J. Cochrane, B. Jarvis and G. M. Keating, Etoricoxib, Drugs62 (2002) 2637--2651.10.2165/00003495-200262180-0000612466002Search in Google Scholar

B. Chauhan, S. Shimpi and A. Paradkar, Preparation and characterization of etoricoxib solid dispersions using lipid carriers by spray drying technique, AAPS PharmSciTech.6 (2005) 405--412; DOI: 10.1208/pt060350.10.1208/pt060350275038416353998Search in Google Scholar

B. N. Suhagia, H. M. Patel, S. A. Shah, I. S. Rathod and V. K. Parmar, Preparation, characterization and in vitro dissolution of etoricoxib-polyethylene glycol 4000-polyvinyl pyrrolidone K30 solid dispersions, Acta Pharm.56 (2006) 285--298.Search in Google Scholar

T. Loftsson and M. Brewster, Pharmaceutical application of cyclodextrins. I. Drug solubilization and stabilization, J. Pharm. Sci.85 (1996) 1017-1025; DOI: 10.1021/js950534b.10.1021/js950534b8897265Search in Google Scholar

R. A. Rajewski and V. J. Stella, Pharmaceutical application of cyclodextrins II. In vivo drug delivery, J. Pharm. Sci.85 (1996) 1142--1169; DOI: 10.1021/js960075u.10.1021/js960075u8923319Search in Google Scholar

K. H. Fromming and J. Szejtli, Cyclodextrins in Pharmacy, Kluwer Academic Publishers, Dordrecht 1994.10.1007/978-94-015-8277-3Search in Google Scholar

K. Uekama, F. Hirayama and I. Tetsumi, Cyclodextrin drug carrier systems, Chem. Rev.98 (1998) 2045-2076; DOI: 10.1021/cr970025p.10.1021/cr970025p11848959Search in Google Scholar

G. P. Betteinetti, A. Gazzania, P. Mura, F. Giordano and M. Setti, The thermal behaviour and dissolution properties of naproxen in combinations with chemically modified β-cyclodextrins, Drug Dev. Ind. Pharm.18 (1992) 39--53.Search in Google Scholar

T. Higuchi and K. A. Connors, Phase solubility techniques, Adv. Anal. Chem. Instrum.4 (1965) 207--212.Search in Google Scholar

USP XXIII, NF XVIII, USP Convention, Rockville 1995, pp. 1791--1799.Search in Google Scholar

K. A. Khan and C. T. Rhodes, The concept of dissolution efficiency, J. Pharm. Pharmacol.27 (1975) 48--49.Search in Google Scholar

C. Lefebvre, A. M. Barthelemy and G. Hermann, An attempt at bringing to light a phase inversion in a binary mixture of two dimensional rounded particles, Drug Dev. Ind. Pharm.14 (1988) 2443--2465.Search in Google Scholar

P. Mura, M. T. Faucci and P. L. Parrini, Effects of grinding with microcrystalline cellulose and cyclodextrins on the ketofen physicochemical properties, Drug Dev. Ind. Pharm.27 (2001) 119--128; DOI: 10.1081/DDC-100000478.10.1081/DDC-10000047811266223Search in Google Scholar

• Recent approaches in the drug research and development of novel antimalarial drugs with new targets
• Intensive critical care and management of asthmatic and smoker patients in COVID-19 infection
• Effects of tranquilization therapy in elderly patients suffering from chronic non-communicable diseases: A meta-analysis
• The opposite effect of convulsant drugs on neuronal and endothelial nitric oxide synthase – A possible explanation for the dual proconvulsive/anticonvulsive action of nitric oxide
• Ampelopsin induces MDA-MB-231 cell cycle arrest through cyclin B1-mediated PI3K/AKT/mTOR pathway in vitro and in vivo
• Effects of 3R, 16S-2-hydroxyethyl apovincaminate (HEAPO), donepezil and galantamine on learning and memory retention in naïve Wistar rats
• Tablet characteristics and pharmacokinetics of orally disintegrating tablets containing coenzyme Q10 granules prepared by different methods
• Sodium butyrate attenuate hyperglycemia-induced inflammatory response and renal injury in diabetic mice
• Diethylene glycol monoethyl ether-mediated nanostructured lipid carriers enhance trans-ferulic acid delivery by Caco-2 cells superior to solid lipid nanoparticles
• The in vitro anticancer effects of FS48 from salivary glands of Xenopsylla cheopis on NCI-H460 cells via its blockage of voltage-gated K⁺ channels